Cargando…

Evidence from a meta-analysis: is nivolumabneurotoxic in cancer patients?

The aim of this study was to summarize the findings of previous studies focusing on whether the risks of certain neurotoxicities are correlated to the programmed death 1 (PD-1) inhibitor nivolumab versus other chemotherapy or immunotherapy drugs. Six eligible studies, including 3,023 patients, were...

Descripción completa

Detalles Bibliográficos
Autores principales: Kong, Xiangyi, Kong, Yanguo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5338929/
https://www.ncbi.nlm.nih.gov/pubmed/28280368
http://dx.doi.org/10.2147/OTT.S120341